Genetic Analysis: Flagging notification
OSLO, NORWAY – July 1, 2024: Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) hereby announces that an existing shareholder, Muen Invest AS, crosses the flagging threshold as…
Genetic Analysis announces placement of a directed share issue of approximately NOK 4.97 million
Genetic Analysis AS (“GA” or the “Company”) is pleased to announce that it has successfully placed a directed issue and on basis of commitments received from current major shareholders, the…
Genetic Analysis: Awarded important EU patent covering a companion diagnostic method for optimising IBS interventions
OSLO, NORWAY – 13 June 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today the grant of an important patent (EP3526340) by the European Patent Office…
Genetic Analysis AS: CFO resigns to pursue other opportunities
OSLO, NORWAY – 06 June 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that Eilert Aamodt has decided to resign as CFO to take on a…
Genetic Analysis AS: Mandatory notification of trade – Primary Insider
OSLO, NORWAY – 3 June 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the board of directors has bought GEAN-shares. Jethro Holter, Chairperson of Genetic…
Genetic Analysis AS: Mandatory notification of trade – Primary Insider
OSLO, NORWAY – 31 May 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the board of directors has bought GEAN-shares. Jethro Holter, Chairperson of Genetic…
Genetic Analysis AS: Publication of Q1 report January – March 2024
OSLO, NORWAY – May 29, 2024: Today, Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) hereby publishes the interim report for the period January 1 – March 31,…
Minutes from the Annual General Meeting 2024
in Genetic Analysis AS Oslo, Norway, May 15, 2024 – Genetic Analysis AS (the “Company”, Ticker: GEAN) held its Annual General Meeting yesterday, May 14th, at 15:00 hours (CET) on…
Genetic Analysis AS: Mandatory notification of trade – Primary Insider
OSLO, NORWAY – 19 April 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares. Ronny Hermansen, CEO of Genetic Analysis AS,…
Genetic Analysis AS: Publication of Annual Report 2023
Oslo, Norway, April 18, 2024 – Genetic Analysis AS (the “Company”, Ticker: GEAN) hereby publishes the Annual Report for the financial year of 2023. The Annual Report is available as…
Genetic Analysis AS: Mandatory notification of trade – Primary Insider
OSLO, NORWAY – 14 March 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares. Christina Casén, SVP Clinical & Medical Affairs…
Genetic Analysis AS: Mandatory notification of trade – Primary Insider
OSLO, NORWAY – 11 March 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares. Ronny Hermansen, CEO of Genetic Analysis AS,…
Year-end report January – December 2023
Oslo, Norway, February 29, 2024 – Genetic Analysis AS (the “Company”, Ticker: GEAN) hereby publishes the year-end report for the period 1 January – December 31, 2023. The year-end report…
Genetic Analysis AS announces CE-IVDR marking for its GA-map® Sample Collection Kit
Oslo, Norway, November 26, 2024 – Genetic Analysis AS (the “Company”, Ticker: GEAN) is proud to announce that its GA-map® Sample Collection Kit has obtained CE-IVD marking under the In…
Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises
Genetic Analysis AS’ (“GA” or the “Company”) subsequent offering to existing shareholders, for which the subscription period ended on December 22, 2023 (the “Subsequent Offering”), has now been registered with…